Table 1.
Demographic and clinical characteristics of the patients included in the present study
| Characteristics | COVID-19 group (N = 122) | Influenza group (N = 48) | p value |
|---|---|---|---|
| Sex | |||
| Male | 61 (50%) | 23 (48%) | 0.807 |
| Female | 61 (50%) | 25 (52%) | |
| Age (years) | 48 ± 15 (range 15–80) | 47 ± 19 (range 15–86) | 0.886 |
| Wuhan contact | |||
| Yes | 102 (83%) | – | |
| No | 20 (17%) | – | |
| Comorbidity | |||
| Diabetes | 13 (11%) | 2 (4%) | 0.179 |
| Hypertension | 10 (8%) | 3 (6%) | 0.667 |
| Chronic obstructive pulmonary disease | 4 (3%) | 6 (13%) | 0.021 |
| Cardiovascular disease | 3 (2%) | 3 (6%) | 0.228 |
| Hepatic disease | 3 (2%) | 0 | 0.273 |
| Malignancy | 2 (1%) | 1 (2%) | 0.843 |
| Symptoms | |||
| No obvious symptoms | 7 (6%) | 0 | 0.090 |
| Fever | 90 (74%) | 40 (83%) | 0.186 |
| Cough | 77 (63%) | 37 (77%) | 0.081 |
| Sputum | 15 (12%) | 10 (21%) | 0.157 |
| Stuffy and runny nose | 8 (7%) | 11 (23%) | 0.002 |
| Dyspnea | 12 (10%) | 7 (15%) | 0.153 |
| Headache | 17 (14%) | 4 (8%) | 0.318 |
| Nausea and vomit | 3 (2%) | 2 (4%) | 0.553 |
| Chest pain | 3 (2%) | 2 (4%) | 0.553 |
| Sore throat | 10 (8%) | 7 (15%) | 0.211 |
| Diarrhea | 4 (3%) | 2 (4%) | 0.778 |
| Clinical outcome | |||
| Died | 3 (2%) | 2 (4%) | 0.553 |
| Discharged | 119(98%) | 46 (96%) | |
Italicized entries when P < 0.05